A daily dose of aspirin may have a moderate effect in lowering a man's risk of prostate cancer, according to a new study.
Authors of the research - involving 30 000 American men ages 55 to 74 - found that participants who took a daily aspirin had a 15 percent lower risk of developing prostate cancer than non-users; those who took two aspirin a day had a 20 percent lower risk, according to an account from the Milwaukee Journal Sentinel.
Aspirin against other cancers
Aspirin is a non-steroidal anti-inflammatory drug (NSAID) that blocks an inflammation-triggering substance called COX-2. Past research has shown several links between the substance and the formation and spread of various cancers.
The research was funded by the American National Cancer Institute as part of its Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial being conducted at 10 sites around the country, the newspaper said.
One in ten men will develop clinically significant prostate cancer in their lifetime. – (HealthDayNews)